Fresh2 Group Limited (FREHY)

Market Cap	222.26K
Revenue (ttm)	2.34M
Net Income (ttm)	-17.18M
Shares Out	2.22M
EPS (ttm)	-38.77
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,391
Average Volume	18,276
Open	0.1000
Previous Close	0.1000
Day's Range	0.1000 - 0.1000
52-Week Range	0.1000 - 6.6000
Beta	1.36
RSI	20.89
Earnings Date	May 15, 2025

About Fresh2 Group

Fresh2 Group Limited, a biotechnology company, researches, develops, markets, and sells multi-cancer screening and detection tests using cancer differentiation analysis technology and device to corporations and life insurance companies in the People’s Republic of China. It also offers physical checkup packages, as well as technology services comprising market research, designing, coding, developing, testing, etc. In addition, the company sells genetic testing kits and skin-care products; and owns core technology platforms, as well as engages in...

• Industry: Biological Products, Except Diagnostic Substances
• Founded: 2010
• Employees: 75
• Stock Exchange: OTCMKTS
• Ticker Symbol: FREHY

Financial Performance

In 2022, Fresh2 Group's revenue was 12.04 million, a decrease of -33.04% compared to the previous year's 17.99 million. Losses were -101.89 million, -14.16% less than in 2021.

Financial numbers in CNY